| Human urotensin-II is a potent vasoconstrictor and agonist for the orphan receptor GPR14 RS Ames, HM Sarau, JK Chambers, RN Willette, NV Aiyar, AM Romanic, ... Nature 401 (6750), 282-286, 1999 | 1240 | 1999 |
| Applications of micro-CT and MR microscopy to study pre-clinical models of osteoporosis and osteoarthritis RD Kapadia, GB Stroup, AM Badger, B Koller, JM Levin, RW Coatney, ... Technology and health care 6 (5-6), 361-372, 1998 | 157 | 1998 |
| Monocyte chemoattractant protein-1 is upregulated in rats with volume-overload congestive heart failure TM Behr, X Wang, N Aiyar, RW Coatney, X Li, P Koster, CE Angermann, ... Circulation 102 (11), 1315-1322, 2000 | 150 | 2000 |
| Hypertensive end-organ damage and premature mortality are p38 mitogen-activated protein kinase–dependent in a rat model of cardiac hypertrophy and dysfunction TM Behr, SS Nerurkar, AH Nelson, RW Coatney, TN Woods, A Sulpizio, ... Circulation 104 (11), 1292-1298, 2001 | 145 | 2001 |
| Effects of p38 MAPK Inhibitor on angiotensin II-dependent hypertension, organ damage, and superoxide anion production W Bao, DJ Behm, SS Nerurkar, Z Ao, R Bentley, RC Mirabile, DG Johns, ... Journal of cardiovascular pharmacology 49 (6), 362-368, 2007 | 117 | 2007 |
| GW427353 (solabegron), a novel, selective β3-adrenergic receptor agonist, evokes bladder relaxation and increases micturition reflex threshold in the dog A Hicks, GP McCafferty, E Riedel, N Aiyar, M Pullen, C Evans, TD Luce, ... Journal of Pharmacology and Experimental Therapeutics 323 (1), 202-209, 2007 | 115 | 2007 |
| Deletion of the UT receptor gene results in the selective loss of urotensin‐II contractile activity in aortae isolated from UT receptor knockout mice DJ Behm, SM Harrison, Z Ao, K Maniscalco, SJ Pickering, EV Grau, ... British journal of pharmacology 139 (2), 464-472, 2003 | 80 | 2003 |
| Human urotensin-II is a potent vasoactive peptide: pharmacological characterization in the rat, mouse, dog and primate SA Douglas, DJ Ashton, CF Sauermelch, RW Coatney, DH Ohlstein, ... Journal of cardiovascular pharmacology 36, S163-S166, 2000 | 79 | 2000 |
| Differences in effects on myocardium and mitochondria by angiogenic inhibitors suggest separate mechanisms of cardiotoxicity KJ French, RW Coatney, JP Renninger, CX Hu, TL Gales, S Zhao, ... Toxicologic pathology 38 (5), 691-702, 2010 | 70 | 2010 |
| Comparison of soluble guanylate cyclase stimulators and activators in models of cardiovascular disease associated with oxidative stress MH Costell, N Ancellin, RE Bernard, S Zhao, JJ Upson, LA Morgan, ... Frontiers in pharmacology 3, 128, 2012 | 67 | 2012 |
| Gastric pH and gastric residence time in fasted and fed conscious beagle dogs using the Bravo® pH system KM Mahar, S Portelli, R Coatney, EP Chen Journal of pharmaceutical sciences 101 (7), 2439-2448, 2012 | 63 | 2012 |
| Gastric pH and gastric residence time in fasted and fed conscious cynomolgus monkeys using the Bravo® pH system EP Chen, KM Mahar Doan, S Portelli, R Coatney, V Vaden, W Shi Pharmaceutical research 25, 123-134, 2008 | 55 | 2008 |
| Eprosartan improves cardiac performance, reduces cardiac hypertrophy and mortality and downregulates myocardial monocyte chemoattractant protein-1 and inflammation in … TM Behr, RN Willette, RW Coatney, M Berova, CE Angermann, ... Journal of hypertension 22 (3), 583-592, 2004 | 55 | 2004 |
| Hypertensive target organ damage is attenuated by a p38 MAPK inhibitor: role of systemic blood pressure and endothelial protection AR Olzinski, TA McCafferty, SQ Zhao, DJ Behm, ME Eybye, K Maniscalco, ... Cardiovascular research 66 (1), 170-178, 2005 | 50 | 2005 |
| Eprosartan reduces cardiac hypertrophy, protects heart and kidney, and prevents early mortality in severely hypertensive stroke-prone rats FC Barone, RW Coatney, S Chandra, SK Sarkar, AH Nelson, LC Contino, ... Cardiovascular research 50 (3), 525-537, 2001 | 50 | 2001 |
| Differential effects of p38 mitogen-activated protein kinase and cyclooxygenase 2 inhibitors in a model of cardiovascular disease RN Willette, ME Eybye, AR Olzinski, DJ Behm, N Aiyar, K Maniscalco, ... Journal of Pharmacology and Experimental Therapeutics 330 (3), 964-970, 2009 | 47 | 2009 |
| Meniscal ossification in spontaneous osteoarthritis in the guinea-pig RD Kapadia, AM Badger, JM Levin, B Swift, A Bhattacharyya, RA Dodds, ... Osteoarthritis and Cartilage 8 (5), 374-377, 2000 | 45 | 2000 |
| A novel method for chronic measurement of respiratory function in the conscious monkey DJ Murphy, JP Renninger, RW Coatney Journal of pharmacological and toxicological methods 46 (1), 13-20, 2001 | 36 | 2001 |
| Technologies: preclinical imaging for drug development PM Matthews, R Coatney, H Alsaid, B Jucker, S Ashworth, C Parker, ... Drug Discovery Today: Technologies 10 (3), e343-e350, 2013 | 33 | 2013 |
| Use of diffusion-weighted MRI and neurological deficit scores to demonstrate beneficial effects of isradipine in a rat model of focal ischemia S Chandra, RF White, D Everding, GZ Feuerstein, RW Coatney, ... Pharmacology 58 (6), 292-299, 1999 | 29 | 1999 |
